---
language:
  - en
license: mit
pretty_name: Pharma Reimbursement Path Optimization Forecasting v0.1
dataset_name: pharma-reimbursement-path-optimization-forecasting-v0.1
tags:
  - clarusc64
  - pharma
  - market-access
  - payer
  - HTA
  - RWE
task_categories:
  - tabular-classification
  - tabular-regression
size_categories:
  - n<1K
configs:
  - config_name: default
    data_files:
      - split: train
        path: data/train.csv
      - split: test
        path: data/test.csv
---

What this dataset tests

Whether a system can forecast a robust reimbursement pathway  
from payer pressure, evidence constraints, and pricing limits.

Required outputs

- optimal_endpoint_mix  
- RWE_generation_plan  
- pricing_stability_zone  
- access_probability  
- restriction_burden_forecast  
- coverage_stability_horizon  
- confidence_score  

Use case

Phase III design for reimbursement success.  
RWE planning that closes payer gaps.  
Pricing posture and restriction forecasting.